Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man

Journal of Psychopharmacology

Volumn 16, Issue 3, 2002, Pages 207-214

  Schmitt, Jeroen A J ^a   Ramaekers, Johannes G ^a   Kruizinga, Monique J ^a   Van Boxtel, Martin P J ^a   Vuurman, Eric F P M ^a   Riedel, Wim J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Attention drug effects; Dopamine; Paroxetine; Serotonin drug effects; Sertraline; Vigilance

Indexed keywords

DOPAMINE; DOPAMINE UPTAKE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ALERTNESS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DICHOTIC LISTENING; DOPAMINE UPTAKE; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL PERFORMANCE; NAUSEA; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SELECTIVE ATTENTION; SEROTONIN UPTAKE; SEROTONINERGIC TRANSMISSION; TASK PERFORMANCE; VERTIGO;

EID: 0036731656     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600303     Document Type: Article

References (45)

1. Subjective sleep ratings: The effects of sleep deprivation, circadian rhythmicity and cognitive performance
2. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes
3. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: A review
4. Extrapyramidal reactions and the selective serotonin reuptake inhibitors
5. Effects of locus coeruleus lesions on vigilance and attentive behaviour in cat
6. Selective serotonin reuptake inhibitors reduce spontaneous activity of dopaminergic neurons in the ventral tegmental area
7. Systematic review and guide to selection of selective serotonin reuptake inhibitors
8. Selective serotonin reuptake inhibitors in affective disorders - II. Efficacy and quality of life
9. Sertraline treatment does not increase plasma prolactine levels in healthy subjects
10. A review of the psychomotor effects of paroxetine
11. Psychopharmacological effects of sertraline in normal, healthy volunteers
12. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
13. Extrapyramidal symptoms associated with selective serotonin reuptake inhibitors
14. Serotonin-dopamine interaction and its relevance to schizophrenia
15. Benzodiazepines and vigilance performance: A review
16. Stimulant drugs and vigilance performance: A review
17. Cognitive and psychomotor effects of antidepressants with emphasis on selective serotonin reuptake inhibitors and the depressed elderly patient
18. Does haloperidol block methylphenidate? Motivation or attention?
19. Researches on the measurement of human performance
20. Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance fo healthy subjects over 50 years of age
21. Lack of effects of lesions of the dorsal noradrenergic bundle on behavioral vigilance
22. The neuropsychology of attention
23. Dopaminergic transmission and the sleep-wakefulness continuum in man
24. Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens
25. Boredom: Practical consequences and a theory
26. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality
27. Pharmacologically induced changes in arousal: Effects on behavioral and electrophysiologic measures of alertness and attention
28. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance
29. Synaptic effects of antidepressants
30. Mechanisms of drug-induced driving impairment: A dimensional approach
31. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers
32. Arousal systems and attention
33. Cortical noradrenaline, attention and arousal
34. Arousal systems and attentional processes
35. Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects
36. Energetics, stress and sustained attention
37. The cognitive neuroscience of sustained attention: Where top-down meets bottom-up
38. Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers
39. Dopamine and the mechanisms of cognition: Part II. D-amphetamine effects in human subjects performing a selective attention task
40. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action
41. Studies of interference in serial verbal reactions
42. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
43. A self rating depression scale